These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8799879)

  • 1. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of staurosporine derivatives on protein kinase activity and vinblastine accumulation in mouse leukaemia P388/ADR cells.
    Miyamoto K; Inoko K; Ikeda K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    J Pharm Pharmacol; 1993 Jan; 45(1):43-7. PubMed ID: 8094445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein.
    Ayesh S; Litman T; Stein WD
    Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
    Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
    Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine).
    Adams DJ; Knick VC
    Invest New Drugs; 1995; 13(1):13-21. PubMed ID: 7499103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour effects and pharmacokinetics of combination of vinblastine with a staurosporine derivative, NA-382, in P388/ADR-bearing mice.
    Miyamoto K; Takeda K; Koga K; Ohshima T; Wakusawa S
    J Pharm Pharmacol; 1995 Jun; 47(6):524-9. PubMed ID: 7674138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for impaired mitoxantrone and vinblastine binding in P388 murine leukemia cells with multidrug resistance.
    Pincus R; Goldman ID
    Biochem Pharmacol; 1990 Dec; 40(12):2625-35. PubMed ID: 1979735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is rhodamine 123 an appropriate fluorescent probe to assess P-glycoprotein mediated multidrug resistance in vinblastine-resistant CHO cells?
    Pétriz J; O'Connor JE; Carmona M; García-López J
    Anal Cell Pathol; 1997; 14(3):129-40. PubMed ID: 9354229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
    Mayer LD; Lim KT; Hartley D
    J Exp Ther Oncol; 2002; 2(2):107-20. PubMed ID: 12415627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein.
    Siegsmund MJ; Kreukler C; Steidler A; Nebe T; Köhrmann KU; Alken P
    Urol Res; 1997; 25(1):35-41. PubMed ID: 9079744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S; Patel K; Singh H; Gollapudi S
    Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturation reversal of the multidrug pump using many reversers in low-dose combinations.
    Lyubimov E; Lan LB; Pashinsky I; Ayesh S; Stein WD
    Anticancer Drugs; 1995 Dec; 6(6):727-35. PubMed ID: 8845484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.